Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

被引：58

作者：

Li, Tingting ^{[1
,2
]}

Xue, Wenhui ^{[1
,2
]}

Zheng, Qingbing ^{[1
,2
]}

Song, Shuo ^{[3
,4
]}

Yang, Chuanlai ^{[1
,2
]}

Xiong, Hualong ^{[1
,2
]}

Zhang, Sibo ^{[1
,2
]}

Hong, Minqing ^{[1
,2
]}

Zhang, Yali ^{[1
,2
]}

Yu, Hai ^{[1
,2
]}

Zhang, Yuyun ^{[1
,2
]}

Sun, Hui ^{[1
,2
]}

Huang, Yang ^{[1
,2
]}

Deng, Tingting ^{[1
,2
]}

Chi, Xin ^{[1
,2
]}

Li, Jinjin ^{[1
,2
]}

Wang, Shaojuan ^{[1
,2
]}

Zhou, Lizhi ^{[1
,2
]}

Chen, Tingting ^{[1
,2
]}

Wang, Yingbin ^{[1
,2
]}

Cheng, Tong ^{[1
,2
]}

Zhang, Tianying ^{[1
,2
]}

Yuan, Quan ^{[1
,2
]}

Zhao, Qinjian ^{[1
,2
]}

Zhang, Jun ^{[1
,2
]}

McLellan, Jason S. ^{[5
]}

Zhou, Z. Hong ^{[6
,7
]}

Zhang, Zheng ^{[3
,4
]}

Li, Shaowei ^{[1
,2
]}

Gu, Ying ^{[1
,2
]}

Xia, Ningshao ^{[1
,2
,8
]}

机构：

[1] Xiamen Univ, Sch Life Sci, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Fujian, Peoples R China

[2] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen 361102, Fujian, Peoples R China

[3] Shenzhen Third Peoples Hosp, Natl Clin Res Ctr Infect Dis, Inst Hepatol, Shenzhen 518112, Guangdong, Peoples R China

[4] Southern Univ Sci & Technol, Sch Med, Affiliated Hosp 2, Shenzhen 518112, Guangdong, Peoples R China

[5] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA

[6] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90095 USA

[7] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA

[8] Chinese Acad Med Sci, Res Unit Frontier Technol Struct Vaccinol, Xiamen 518112, Fujian, Peoples R China

来源：

NATURE COMMUNICATIONS | 2021年 / 12卷 / 01期

基金：

中国国家自然科学基金;

关键词：

CRYO-EM STRUCTURE; INFLUENZA; INFECTION; PROTECT; DOMAIN; VIRUS; SPIKE; IGG;

D O I：

10.1038/s41467-021-25997-3

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The emergence of numerous variants of SARS-CoV-2, the causative agent of COVID-19, has presented new challenges to the global efforts to control the COVID-19 pandemic. Here, we obtain two cross-neutralizing antibodies (7D6 and 6D6) that target Sarbecoviruses' receptor-binding domain (RBD) with sub-picomolar affinities and potently neutralize authentic SARS-CoV-2. Crystal structures show that both antibodies bind a cryptic site different from that recognized by existing antibodies and highly conserved across Sarbecovirus isolates. Binding of these two antibodies to the RBD clashes with the adjacent N-terminal domain and disrupts the viral spike. Both antibodies confer good resistance to mutations in the currently circulating SARS-CoV-2 variants. Thus, our results have direct relevance to public health as options for passive antibody therapeutics and even active prophylactics. They can also inform the design of pan-sarbecovirus vaccines. Antibodies (Abs) targeting highly conserved epitopes are important tools against emerging virus variants. Here, the authors characterize Abs that recognize a cryptic epitope in the receptor-binding domain of SARS-CoV-2 spike that is well conserved and show that these Abs can neutralize several variants of concerns.

引用

页数：12

共 69 条

[1] PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].

Adams, Paul D. ;

Afonine, Pavel V. ;

Bunkoczi, Gabor ;

Chen, Vincent B. ;

Davis, Ian W. ;

Echols, Nathaniel ;

Headd, Jeffrey J. ;

Hung, Li-Wei ;

Kapral, Gary J. ;

Grosse-Kunstleve, Ralf W. ;

McCoy, Airlie J. ;

Moriarty, Nigel W. ;

Oeffner, Robert ;

Read, Randy J. ;

Richardson, David C. ;

Richardson, Jane S. ;

Terwilliger, Thomas C. ;

Zwart, Peter H. .

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221

[2] A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface [J].

Bangaru, Sandhya ;

Lang, Shanshan ;

Schotsaert, Michael ;

Vanderven, Hillary A. ;

Zhu, Xueyong ;

Kose, Nurgun ;

Bombardi, Robin ;

Finn, Jessica A. ;

Kent, Stephen J. ;

Gilchuk, Pavlo ;

Gilchuk, Iuliia ;

Turner, Hannah L. ;

Garcia-Sastre, Adolfo ;

Li, Sheng ;

Ward, Andrew B. ;

Wilson, Ian A. ;

Crowe, James E., Jr. .

CELL, 2019, 177 (05) :1136-+

[3] SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies [J].

Barnes, Christopher O. ;

Jette, Claudia A. ;

Abernathy, Morgan E. ;

Dam, Kim-Marie A. ;

Esswein, Shannon R. ;

Gristick, Harry B. ;

Malyutin, Andrey G. ;

Sharaf, Naima G. ;

Huey-Tubman, Kathryn E. ;

Lee, Yu E. ;

Robbiani, Davide F. ;

Nussenzweig, Michel C. ;

West, Anthony P., Jr. ;

Bjorkman, Pamela J. .

NATURE, 2020, 588 (7839) :682-+

[4]

Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]

[5] A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations [J].

Bertoglio, Federico ;

Fuehner, Viola ;

Ruschig, Maximilian ;

Heine, Philip Alexander ;

Abassi, Leila ;

Kluenemann, Thomas ;

Rand, Ulfert ;

Meier, Doris ;

Langreder, Nora ;

Steinke, Stephan ;

Ballmann, Rico ;

Schneider, Kai-Thomas ;

Roth, Kristian Daniel Ralph ;

Kuhn, Philipp ;

Riese, Peggy ;

Schaeckermann, Dorina ;

Korn, Janin ;

Koch, Allan ;

Chaudhry, M. Zeeshan ;

Eschke, Kathrin ;

Kim, Yeonsu ;

Zock-Emmenthal, Susanne ;

Becker, Marlies ;

Scholz, Margitta ;

Moreira, Gustavo Marcal Schmidt Garcia ;

Wenzel, Esther Veronika ;

Russo, Giulio ;

Garritsen, Hendrikus S. P. ;

Casu, Sebastian ;

Gerstner, Andreas ;

Roth, Guenter ;

Adler, Julia ;

Trimpert, Jakob ;

Hermann, Andreas ;

Schirrmann, Thomas ;

Duebel, Stefan ;

Frenzel, Andre ;

Van den Heuvel, Joop ;

Cicin-Sain, Luka ;

Schubert, Maren ;

Hust, Michael .

CELL REPORTS, 2021, 36 (04)

[6] Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability [J].

Brouwer, Philip J. M. ;

Caniels, Tom G. ;

van der Straten, Karlijn ;

Snitselaar, Jonne L. ;

Aldon, Yoann ;

Bangaru, Sandhya ;

Torres, Jonathan L. ;

Okba, Nisreen M. A. ;

Claireaux, Mathieu ;

Kerster, Gius ;

Bentlage, Arthur E. H. ;

van Haaren, Marlies M. ;

Guerra, Denise ;

Burger, Judith A. ;

Schermer, Edith E. ;

Verheul, Kirsten D. ;

van der Velde, Niels ;

van der Kooi, Alex ;

van Schooten, Jelle ;

van Breemen, Marielle J. ;

Bijl, Tom P. L. ;

Sliepen, Kwinten ;

Aartse, Aafke ;

Derking, Ronald ;

Bontjer, Ilja ;

Kootstra, Neeltje A. ;

Wiersinga, W. Joost ;

Vidarsson, Gestur ;

Haagmans, Bart L. ;

Ward, Andrew B. ;

de Bree, Godelieve J. ;

Sanders, Rogier W. ;

van Gils, Marit J. .

SCIENCE, 2020, 369 (6504) :643-+

[7] MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses [J].

Bruchez, Anna ;

Sha, Ky ;

Johnson, Joshua ;

Chen, Li ;

Stefani, Caroline ;

McConnell, Hannah ;

Gaucherand, Lea ;

Prins, Rachel ;

Matreyek, Kenneth A. ;

Hume, Adam J. ;

Muhlberger, Elke ;

Schmidt, Emmett V. ;

Olinger, Gene G. ;

Stuart, Lynda M. ;

Lacy-Hulbert, Adam .

SCIENCE, 2020, 370 (6513) :241-+

[8]

Burki T, 2021, LANCET, V397, P462, DOI 10.1016/S0140-6736(21)00298-1

[9] The prevalence of antibodies to SARS-CoV-2 among blood donors in China [J].

Chang, Le ;

Hou, Wangheng ;

Zhao, Lei ;

Zhang, Yali ;

Wang, Yanbin ;

Wu, Linfeng ;

Xu, Tingting ;

Wang, Lilin ;

Wang, Juan ;

Ma, Jian ;

Wang, Lan ;

Zhao, Junpeng ;

Xu, Jing ;

Dong, Juan ;

Yan, Ying ;

Yang, Ru ;

Li, Yu ;

Guo, Fei ;

Cheng, Wenjuan ;

Su, Yingying ;

Zeng, Jinfeng ;

Han, Wei ;

Cheng, Tong ;

Zhang, Jun ;

Yuan, Quan ;

Xia, Ningshao ;

Wang, Lunan .

NATURE COMMUNICATIONS, 2021, 12 (01)

[10] MolProbity: all-atom structure validation for macromolecular crystallography [J].

Chen, Vincent B. ;

Arendall, W. Bryan, III ;

Headd, Jeffrey J. ;

Keedy, Daniel A. ;

Immormino, Robert M. ;

Kapral, Gary J. ;

Murray, Laura W. ;

Richardson, Jane S. ;

Richardson, David C. .

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :12-21

← 1 2 3 4 5 6 7 →